In:
Cancer, Wiley, Vol. 122, No. 6 ( 2016-03-15), p. 917-928
Kurzfassung:
It is currently unclear whether the dosimetric advantages of organ sparing by intensity‐modulated radiotherapy (IMRT) compared with 3‐dimensional conformal radiotherapy translate into survival and cardiopulmonary mortality benefits in patients with esophageal cancer. This Surveillance, Epidemiology, and End Results‐Medicare and Texas Cancer Registry‐Medicare population‐based study found that although there were no differences noted with regard to cancer‐specific or pulmonary‐specific mortality, all‐cause and cardiac‐specific mortality rates were found to be significantly reduced in patients treated with IMRT on a propensity score‐adjusted multivariate analysis.
Materialart:
Online-Ressource
ISSN:
0008-543X
,
1097-0142
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2016
ZDB Id:
1479932-7
ZDB Id:
2599218-1
ZDB Id:
2594979-2
ZDB Id:
1429-1
